Yongzhang Luo

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 14, 2025
Correction: TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.

Caihong Wang, Shaosen Zhang, Boyuan Ma

|Mar 08, 2022
TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.

Caihong Wang, Shaosen Zhang, Boyuan Ma

Pageof 1

Frequent Collaborators